THE SPECIFY STUDY (completed study)
The SPECIFY study is a non-interventional study aiming to develop a complex score composed by clinical data, genomic data and protein biomarkers to early predict patients with infection by Clostridium difficile at high likelihood to develop organ failure, relapse of the infection or die.
Study title: “Scoring PErsonalized needs in Clostridium difficile Infections for Fidaxomixin therapY”.
ClinicalTrials.gov NCT02573571
Duration: September 2015 to December 2016
Study phase: II
Number of Study sites: 11
Total number of enrolled patients: 153
Study site |
PI |
Enrolled pts |
|---|---|---|
5th Department of Internal Medicine, Evangelismos General Hospital |
A.Skoutelis |
31 |
4th Department of Internal Medicine, Attikon university Hospital |
E.Giamarellos |
29 |
1st Department of Internal Medicine, G. Gennimatas General Hospital |
P.Gargalianos |
21 |
1st Department of Internal Medicine, Thriasion General Hospital |
S.Symbardi |
20 |
Department of Infectious Diseases, Tzaneio General Hospital |
G. Chrysos |
19 |
2nd Department of Internal Medicine, Thriasion General Hospital |
Z. Alexiou |
17 |
3rd Department of Internal Medicine, Sotiria General Hospital |
K. Syrigos |
6 |
1st Department of Internal Medicine, Laiko General Hospital |
G. Daikos |
4 |
1st Department of Internal Medicine, AHEPA University Hospital of Thessaloniki |
S. Metallidis |
3 |
2nd Department of Internal Medicine, Sismanogleio General Hospital |
M. Lada |
2 |
Department of Internal Medicine, University Hospital of Patras |
C. Gogos |
1 |